# Stryker invests $400M in CMR Surgical with option to acquire

Stryker is investing approximately US$400 million in UK surgical robotics developer CMR Surgical, securing an exclusive option to acquire the remaining equity. The agreement also gives Stryker exclusive US commercial agency rights for CMR's Versius surgical robotics portfolio.

- Type: Investment
- Announced: 2026-11-03
- Where: United Kingdom
- Value: $400.0M
- Status: announced
- Products: Versius surgical robotics system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [CMR Surgical](https://endata.com/companies/15356.md)
- [Stryker](https://endata.com/companies/15355.md) (investor)

## Sources

- [pharmafile.com](https://pharmafile.com/news/stryker-invests-us400m-in-cmr-surgical-and-secures-option-to-acquire-business/), 2026-11-03: "Andy Pierce, Group President of MedSurg and Neurotechnology at Stryker, described soft-tissue robotics as a high-growth opportunity and said the company had selected CMR after evaluating the sector over several years."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.